XML 24 R10.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Statements of Cash Flows - USD ($)
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash Flows from Operating Activities:    
Net income (loss) $ (8,691,938) $ 11,067,877
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Change in unrealized (gain) loss on open commodity futures contracts (5,867,437) 3,604,090
(Increase) decrease in receivable from General Partner 56,363 (11,899)
(Increase) decrease in dividends receivable 33,286 (72,544)
(Increase) decrease in interest receivable (3,092) (8,367)
(Increase) decrease in prepaid other (608) (5,432)
(Increase) decrease in prepaid insurance [1] (4,489) (1,175)
Increase (decrease) in General Partner management fees payable (9,257) 15,797
Increase (decrease) in professional fees payable (54,406) 23,275
Increase (decrease) in directors' fees payable [1] (23) 52
Net cash provided by (used in) operating activities (14,541,601) 14,611,674
Cash Flows from Financing Activities:    
Addition of partnership shares 7,702,010 41,366,621
Redemption of partnership shares (7,160,591) (30,218,789)
Net cash provided by (used in) financing activities 541,419 11,147,832
Net Increase (Decrease) in Cash and Cash Equivalents (14,000,182) 25,759,506
Total Cash, Cash Equivalents and Equity in Trading Accounts, beginning of period 33,256,800 15,705,957
Total Cash, Cash Equivalents and Equity in Trading Accounts, end of period 19,256,618 41,465,463
Components of Cash, Cash Equivalents, and Equity in Trading Accounts    
Cash and cash equivalents 14,269,653 32,489,448
Equity in Trading Accounts:    
Cash and cash equivalents 4,986,965 8,976,015
Total Cash, Cash Equivalents and Equity in Trading Accounts $ 19,256,618 $ 41,465,463
[1] Certain prior year amounts have been reclassified for consistency with the current presentation.